Cristian Rodriguez
Medical · Grand Rapids, MINPI 1760760037
Payments from drug & device makers
Across 204 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$554
- Supernus Pharmaceuticals, Inc.$433
- AstraZeneca$361
- Novo Nordisk$340
- Otsuka America Pharmaceutical, Inc.$264
- GSK$254
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,886100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $554 |
| Supernus Pharmaceuticals, Inc. | 22 | $433 |
| AstraZeneca(2 entities) | 16 | $361 |
| Novo Nordisk | 13 | $340 |
| Otsuka America Pharmaceutical, Inc. | 16 | $264 |
| GSK | 15 | $254 |
| Pfizer | 10 | $222 |
| Indivior Inc. | 11 | $196 |
| Lundbeck LLC | 7 | $179 |
| Lilly USA, LLC | 9 | $166 |
| Orexo US, Inc. | 7 | $128 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $126 |
| USWM, LLC | 3 | $101 |
| Exact Sciences | 6 | $100 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| E.r. Squibb & Sons, L.L.C. | 3 | $64 |
| Braeburn Inc. | 3 | $62 |
| Johnson & Johnson | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $33 |
| Tonix Medicines, Inc. | 1 | $27 |
| Novartis | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,886 in reported general payments places this provider in the 85th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 24 | $33,834 |
| TrulicityDulaglutide | 28 | $30,314 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 209 | $21,605 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $18,089 |
| OzempicSemaglutide | 20 | $17,975 |
| FarxigaDapagliflozin Propanediol | 16 | $16,920 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 15 | $4,204 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $1,830 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $1,729 |
| Atorvastatin Calcium | 79 | $799 |
| Metformin Hcl | 59 | $722 |
| Levothyroxine Sodium | 38 | $597 |
| Duloxetine Hcl | 19 | $597 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $560 |
| Fluticasone Propionate | 30 | $542 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $166 | $30,31428 claims |
| GSKTrelegy Ellipta | $254 | $18,08927 claims |
| Novo NordiskOzempic | $340 | $17,97520 claims |
| AstraZenecaFarxiga | $361 | $16,92016 claims |
| Orexo US, Inc.Zubsolv | $128 | $4,20415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 755 medical providers in Michigan.
Other medical in Grand Rapids
- Meredith KentGrand Rapids$192K
- David BarneyGrand Rapids$21K
- Nisha McKenzieGrand Rapids$19K
- Brenda WhartonGrand Rapids$11K
- Andra TalaskaGrand Rapids$11K
- Jennifer DykhouseGrand Rapids$8K
- Evan GerondaleGrand Rapids$7K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Amber ShullNorton Shores$154K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.